How Do Wegovy Tablets Survive the Stomach? The SNAC Science

Written by the ClariDay clinical team. Medically reviewed by Ali Salih, GPhC-registered Pharmacist Independent Prescriber.

Reviewed 17 July 2026. Next review 17 August 2026.

Wegovy tablets survive the stomach because each one carries an absorption enhancer called SNAC. It briefly buffers the acid around the tablet, protects the semaglutide from being digested, and helps a small amount cross the stomach lining into the blood. That amount is small and easily disrupted, which is why the tablet is taken on an empty stomach. The semaglutide tablet was licensed in the UK by the MHRA on 11 June 2026, and it is a prescription-only medicine [1].

Here is the part that catches people out. Semaglutide is a peptide, a small chain of protein, and the stomach exists to break protein down. So a protein medicine you swallow ought to be digested before it can do anything at all. For years that was the accepted limit, and it is why this class of medicine arrived first as an injection. The tablet gets around the problem with a single piece of formulation, and once you understand it, the unusual instructions stop feeling arbitrary. This page is about that one piece of formulation, and what it means for you.

How do Wegovy tablets work? The short version

Wegovy tablets work by pairing semaglutide with a helper molecule, SNAC, that carries a fraction of it across the stomach lining. Three things happen in the few minutes after the tablet dissolves:

1. It is protected. SNAC buffers the acid in a small pocket around the tablet, so the stomach's digestive enzymes cannot break the semaglutide down.

2. It is kept usable. SNAC stops the semaglutide molecules clumping together, which keeps them in a form the lining can absorb.

3. It is let through. SNAC briefly makes the lining more permeable, the semaglutide crosses into the blood, and then the effect reverses.

The rest of this article is those three steps in more detail, and the one number that ties them together.

Why can't you just swallow semaglutide on its own?

On its own, it would not last. Two things in the stomach work against it. Acid is the obvious one. The less obvious one is pepsin, an enzyme the stomach makes specifically to cut protein into pieces, and semaglutide is protein. Left unprotected, it would be taken apart before any of it could be absorbed [3].

So the difficulty was never the medicine. Semaglutide already worked well as a weekly injection. The question was narrower and harder: how do you move a fragile peptide through an acidic, protein-digesting stomach and still have something intact at the other end. That is the single problem SNAC was built to solve.

What is SNAC, and how does it protect the tablet?

SNAC is the part of the tablet that makes the rest possible. It is not a second active drug. It is an absorption enhancer, present only to carry the semaglutide across the stomach wall, and it does its work in the few minutes after the tablet dissolves, then stops. It protects the medicine in three linked ways, and each answers a different threat [4][5].

The first is the acid and the enzymes. As the tablet dissolves, SNAC acts as a buffer and lifts the pH in a small pocket of fluid around it. That does two things at once. It steadies the semaglutide, and it quietens the stomach's main protein-cutting enzyme, pepsin, by reducing how much of its inactive form is switched on nearby [4]. The aim is not to neutralise the whole stomach, which would be neither possible nor wise. It is to hold a brief pocket of calm in the one place that matters.

The second is clumping. Peptide molecules tend to stick to one another, and once they gather into clusters they are too large to be absorbed well. SNAC keeps them apart, in the single-molecule form the lining can take up. In technical language it reduces oligomerisation [4]. In plain terms, it stops the medicine bunching up.

The third is the crossing. SNAC briefly settles into the surface of the cells lining the stomach and makes them more willing to let the semaglutide pass through them. It does this without forcing open the junctions between cells, the route many other absorption methods rely on. The semaglutide goes through the cells, not between them, and then SNAC lets go and the lining returns to normal. The effect is local, brief, and reversible [3][4][6].

Why is it absorbed in the stomach, not the gut?

Because SNAC only works where the tablet dissolves, and that is the stomach. This is one of the genuinely unusual things about the medicine. Almost every tablet you have ever taken is absorbed further down, in the small intestine. Oral semaglutide is absorbed through the wall of the stomach itself, in a small area right where the tablet has settled [6][7].

That single fact explains most of the instructions that come with it. The window of absorption is not only short in time; it is small in place. It depends on the tablet resting undisturbed against the stomach lining, in a little fluid, long enough for SNAC to do its work. Anything that moves the tablet on, dilutes the fluid around it, or fills the stomach, above all food or a large drink, works against it. You do not need to manage any of this by feel. It is simply why the routine exists, and it is set out step by step in our guide on how to take Wegovy tablets.

Why does so little of the tablet actually get through?

Because even with SNAC, the stomach is an inefficient route, and only a sliver of each dose reaches the blood. The measured figure is about 0.8% [7]. Under recommended conditions, less than one part in a hundred of the tablet is absorbed.

That sounds like a fault. It isn't. It is the honest cost of moving a peptide across the stomach, and the tablet is designed around it. It is why the oral dose is built up to 25mg once daily, while the Wegovy injection works at 2.4mg once weekly [1]. It is not a stronger medicine. It is the same medicine, started at a far higher amount because most of the tablet never makes it through.

There is a second point, and day to day it matters more. Absorption varies, not only between people, but in the same person from one morning to the next. The product information notes that in a small number of people, roughly 2 to 4 in every 100, the tablet produces almost no measurable exposure at all [2]. You would not feel this happening. It is one of the reasons the medicine is prescribed and reviewed rather than simply bought, and it leads to a fair question patients rarely get a straight answer to.

If you can't feel it being absorbed, how do you know it is getting in?

Honestly, you cannot feel absorption itself, and it is worth saying so plainly. Nothing registers when the semaglutide crosses the stomach lining, and because the amount varies, no single morning tells you much on its own.

What you can read, over days and weeks rather than minutes, is the effect once the medicine is in the blood. The earliest honest signal is usually a quiet change in appetite: meals feel like enough sooner, and the pull towards snacks softens. That is a sign the medicine is reaching you. Its absence in the first week or two is not proof it is failing, because the effect builds as the dose is stepped up, and the early doses are deliberately low [1].

Two things are worth not doing. The first is reading side effects as a scoreboard. Feeling queasy is not a measure of how well the tablet was absorbed, and feeling nothing is not a sign it has failed. The second is judging the medicine on a single day. Because absorption varies, it is consistency across weeks that counts, not any one morning. If something genuinely seems off, or the appetite change never comes at all, that is a conversation with your prescriber, not a reason to change the dose yourself. For how the medicine performs over a full course, and who it suits, see what the Wegovy pill is and how well it works.

From the clinic

The hardest thing to explain about oral semaglutide is not how it works, but that you cannot feel it working. That often worries people. They come back after two or three weeks convinced nothing is happening because the scales have barely moved, or because they expected to feel something after taking it.

The reality is rather different. Only a small fraction of the tablet is absorbed, and that varies from day to day. The larger number on the box does not mean a stronger medicine; it simply reflects the more difficult route a tablet must take compared with an injection.

So I encourage people not to judge the treatment by any single morning. Instead, give it a few weeks and look for the quieter changes: feeling satisfied with less food, thinking less about snacks, or noticing your clothes fit differently. Those are usually the first reliable signs that it is doing exactly what it should.

Ali Salih, GPhC-registered Pharmacist Independent Prescriber

In short

Wegovy tablets survive the stomach because SNAC shields the semaglutide, keeps it in an absorbable form, and helps a small amount cross the stomach lining before the effect quietly reverses. Because that amount is small, and easily disrupted, the routine around the tablet is not fussiness. It is the difference between the dose reaching you and being wasted. Understanding the why is usually what makes the how feel worth it.

If you are weighing the tablet against the weekly injection, our guide on whether Wegovy is a pill or an injection compares the two. And if you are considering treatment, you can book a consultation with a prescriber to talk through which option suits you.

This article is general information, not medical advice, and is not a substitute for a consultation with a qualified prescriber.

Frequently asked questions

How do Wegovy tablets survive stomach acid?

Each tablet contains an absorption enhancer called SNAC, which lifts the pH in a small zone around the dissolving tablet. That steadies the semaglutide and quietens the digestive enzyme pepsin nearby, protecting the medicine from being broken down long enough for a small amount to be absorbed through the stomach lining [3][4].

Where are Wegovy tablets absorbed?

In the stomach itself, not further down in the small intestine like most tablets. SNAC briefly makes the cells lining the stomach more permeable, so the semaglutide passes through them into the bloodstream, and then the effect reverses [6][7].

How much of a Wegovy tablet actually gets absorbed?

Very little. The absolute bioavailability is about 0.8%, so under recommended conditions less than 1% of the dose reaches your blood. Absorption also varies a lot between people, and in a small number the tablet produces almost no exposure at all, which is why the medicine is prescribed and reviewed rather than simply bought [7][2].

What is SNAC?

SNAC (sodium N-[8-(2-hydroxybenzoyl)amino] caprylate) is an absorption enhancer built into the tablet. It is not a separate active medicine. Its only job is to protect the semaglutide and help a small amount across the stomach lining, after which its effect is brief and reversible [4][5].

Why is the oral dose (25mg) so much higher than the injection (2.4mg)?

Because so little of a swallowed dose is absorbed. The tablet is not stronger than the injection; it is the same medicine started at a far higher amount to make up for the roughly 0.8% that gets through the stomach [7][1].

Does SNAC change or damage my stomach lining?

No. SNAC works only in the few minutes around the dissolving tablet, and it helps the semaglutide pass through the surface cells without forcing open the junctions between them. Its effect is local, brief and reversible, and the lining returns to normal afterwards [4][6].

References

1. Medicines and Healthcare products Regulatory Agency. (2026, June 11). First GLP-1 tablet for weight loss approved in the UK [Press release]. GOV.UK. https://www.gov.uk/government/news/first-glp-1-tablet-for-weight-loss-approved-in-the-uk

2. Novo Nordisk. Semaglutide tablets: Summary of Product Characteristics (SmPC). electronic medicines compendium. https://www.medicines.org.uk/emc/product/11507/smpc

3. Buckley, S. T., et al. (2018). Transcellular stomach absorption of a derivatized glucagon-like peptide-1 receptor agonist. Science Translational Medicine, 10(467), eaar7047. https://doi.org/10.1126/scitranslmed.aar7047

4. Twarog, C., et al. (2024). Current understanding of sodium N-(8-[2-hydroxylbenzoyl] amino) caprylate (SNAC) as an absorption enhancer: The oral semaglutide experience. Clinical Diabetes, 42(1), 74–86. https://doi.org/10.2337/cd22-0118

5. Aroda, V. R., et al. (2022). A new era for oral peptides: SNAC and the development of oral semaglutide for the treatment of type 2 diabetes. Reviews in Endocrine and Metabolic Disorders, 23(5), 979–994. https://doi.org/10.1007/s11154-022-09735-8

6. Smits, M. M., & Van Raalte, D. H. (2021). Oral semaglutide, the first ingestible glucagon-like peptide-1 receptor agonist. International Journal of Molecular Sciences, 22(18), 9936. https://doi.org/10.3390/ijms22189936

7. Overgaard, R. V., et al. Clinical pharmacokinetics of semaglutide: A systematic review. Drug Design, Development and Therapy. Dove Medical Press. https://www.dovepress.com/clinical-pharmacokinetics-of-semaglutide-a-systematic-review-peer-reviewed-fulltext-article-DDDT